Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
Avid Bioservices (CDMO) Misses Q4 EPS by 5c, Reaffirms Rev. Guidance
September 5, 2019 4:14 PM EDTAvid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $14.36 million.
Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 MillionFor earnings history and earnings-related data on Avid Bioservices (CDMO) click here.
... More


